Monoclonal antibody drugs raise hopes for keeping high-risk COVID-19 patients out of the hospital. But it’s complicated.
There is a need for therapies for mild to moderate COVID-19. It's not clear how much monoclonal antibodies can fill the gap.

There is a need for therapies for mild to moderate COVID-19. It's not clear how much monoclonal antibodies can fill the gap.